November 2, 2024 Tech Titans’ Mixed Results Stall Wall Street Bull Run
October 28, 2024 Recent Oil Slides In Global Markets, Japan In Flux
Apple: Why Outperformance Doesn’t Translate To A Jump In Shares
Nvidia: King Of AI Getting Pumped Up For More
Tesla’s Overpromised Future And Overvalued Stock
Tesla Stock: Why I Remain A Buyer
Tesla Has Too Many Issues To Make For A Solid Investment
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Galapagos NV (GLPG) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: November 5, 2024 (11:38)
Sector: HealthcareThe share price of Galapagos NV (GLPG) now
Are you interested in Galapagos NV stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galapagos NV stock price in 2024, 2025, 2026. How much will one Galapagos NV share be worth in 2024 - 2026?
When should I take profit in Galapagos NV stock? When should I record a loss on Galapagos NV stock? What are analysts' forecasts for Galapagos NV stock? What is the future of Galapagos NV stock? We forecast Galapagos NV stock performance using neural networks based on historical data on Galapagos NV stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Galapagos NV stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Galapagos NV shares. This happens once a day.
Historical and forecast chart of Galapagos NV stock
The chart below shows the historical price of Galapagos NV stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galapagos NV stock price can be found in the table below.
Long-term forecasts by years.
Galapagos NV, a clinical stage biotechnology company, discovers, develops and markets various small molecule drugs. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren’s syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, membranous nephropathy lupus and uveitis.
Galapagos NV daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Nov 07 | 27.00 | 26.59 | 27.56 | 3.66 |
Nov 08 | 27.19 | 26.73 | 27.50 | 2.90 |
Nov 09 | 27.14 | 26.86 | 27.33 | 1.76 |
Nov 10 | 26.53 | 26.08 | 27.11 | 3.94 |
Nov 11 | 27.28 | 26.77 | 27.85 | 4.04 |
Nov 12 | 27.05 | 26.48 | 27.51 | 3.92 |
Nov 13 | 27.46 | 27.04 | 27.78 | 2.74 |
Nov 14 | 27.39 | 26.92 | 27.93 | 3.79 |
Nov 15 | 28.13 | 27.53 | 28.33 | 2.91 |
Nov 16 | 27.94 | 27.35 | 28.61 | 4.60 |
Nov 17 | 27.43 | 26.98 | 27.90 | 3.38 |
Nov 18 | 28.16 | 27.50 | 28.40 | 3.26 |
Nov 19 | 28.28 | 27.70 | 28.59 | 3.22 |
Nov 20 | 28.19 | 27.57 | 28.40 | 2.98 |
Nov 21 | 28.58 | 28.23 | 29.12 | 3.16 |
Nov 22 | 28.24 | 27.88 | 28.66 | 2.80 |
Nov 23 | 28.71 | 28.21 | 29.15 | 3.33 |
Nov 24 | 28.96 | 28.45 | 29.56 | 3.91 |
Nov 25 | 29.23 | 28.86 | 29.93 | 3.71 |
Nov 26 | 29.04 | 28.83 | 29.46 | 2.18 |
Nov 27 | 29.00 | 28.82 | 29.40 | 2.02 |
Nov 28 | 29.02 | 28.53 | 29.66 | 3.94 |
Nov 29 | 28.59 | 28.29 | 29.08 | 2.82 |
Nov 30 | 28.19 | 27.95 | 28.56 | 2.18 |
Dec 01 | 28.95 | 28.68 | 29.37 | 2.39 |
Dec 02 | 28.80 | 28.62 | 29.00 | 1.30 |
Dec 03 | 28.11 | 27.82 | 28.38 | 2.00 |
Dec 04 | 27.95 | 27.42 | 28.58 | 4.25 |
Dec 05 | 27.79 | 27.41 | 27.99 | 2.13 |
Dec 06 | 27.66 | 27.02 | 28.05 | 3.81 |
Galapagos NV Daily Price Targets
Galapagos NV Stock Forecast 11-07-2024.
Forecast target price for 11-07-2024: $27.00.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.527%.
Pessimistic target level: 26.59
Optimistic target level: 27.56
Galapagos NV Stock Forecast 11-08-2024.
Forecast target price for 11-08-2024: $27.19.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 2.818%.
Pessimistic target level: 26.73
Optimistic target level: 27.50
Galapagos NV Stock Forecast 11-09-2024.
Forecast target price for 11-09-2024: $27.14.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 1.727%.
Pessimistic target level: 26.86
Optimistic target level: 27.33
Galapagos NV Stock Forecast 11-10-2024.
Forecast target price for 11-10-2024: $26.53.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 3.787%.
Pessimistic target level: 26.08
Optimistic target level: 27.11
Galapagos NV Stock Forecast 11-11-2024.
Forecast target price for 11-11-2024: $27.28.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.880%.
Pessimistic target level: 26.77
Optimistic target level: 27.85
Galapagos NV Stock Forecast 11-12-2024.
Forecast target price for 11-12-2024: $27.05.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 3.775%.
Pessimistic target level: 26.48
Optimistic target level: 27.51
GLPG (GLPG) Monthly Stock Prediction for 2024
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Dec. | 26.07 | 22.82 | 27.16 | 15.98 |
Galapagos NV forecast for this year
Galapagos NV Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $26.0725. Pessimistic: $22.82. Optimistic: $27.16
Galapagos NV (GLPG) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 25.61 | 24.30 | 27.33 | 11.09 |
Feb | 24.22 | 21.70 | 26.55 | 18.25 |
Mar | 20.38 | 17.97 | 21.88 | 17.88 |
Apr | 17.55 | 16.40 | 19.65 | 16.57 |
May | 18.95 | 17.10 | 19.59 | 12.69 |
Jun | 19.62 | 18.77 | 21.03 | 10.75 |
Jul | 18.46 | 16.18 | 20.32 | 20.35 |
Aug | 17.30 | 16.03 | 18.38 | 12.80 |
Sep | 14.84 | 13.18 | 16.07 | 18.02 |
Oct | 15.31 | 13.43 | 16.39 | 18.09 |
Nov | 13.87 | 12.12 | 15.22 | 20.41 |
Dec | 15.02 | 13.73 | 16.30 | 15.78 |
Galapagos NV (GLPG) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 16.42 | 15.84 | 18.28 | 13.36 |
Feb | 17.34 | 15.76 | 19.11 | 17.56 |
Mar | 19.97 | 18.57 | 20.71 | 10.34 |
Apr | 18.47 | 17.44 | 20.10 | 13.24 |
May | 21.01 | 18.36 | 21.89 | 16.13 |
Jun | 22.39 | 19.88 | 24.11 | 17.53 |
Jul | 24.04 | 20.96 | 25.73 | 18.53 |
Aug | 24.65 | 22.25 | 27.37 | 18.73 |
Sep | 23.15 | 22.12 | 25.04 | 11.69 |
Oct | 22.34 | 21.41 | 25.16 | 14.91 |
Nov | 23.34 | 20.88 | 24.09 | 13.33 |
Dec | 27.04 | 24.35 | 28.72 | 15.21 |
Galapagos NV information and performance
N/A
Market capitalization of the Galapagos NV is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GLPG shares in the company outstanding by the market price of one share.
EBITDA of Galapagos NV is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.